The siren song of bevacizumab: swan song or clarion call? - Wikidata - awgldk - TriplyDB

The siren song of bevacizumab: swan song or clarion call?

The siren song of bevacizumab: swan song or clarion call?

http://www.wikidata.org/entity/Q49818975

about

The siren song of bevacizumab: swan song or clarion call?

http://www.wikidata.org/entity/Q49818975

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The siren song of bevacizumab: swan song or clarion call?

@en

The siren song of bevacizumab: swan song or clarion call?

@nl

type

label

The siren song of bevacizumab: swan song or clarion call?

@en

The siren song of bevacizumab: swan song or clarion call?

@nl

prefLabel

The siren song of bevacizumab: swan song or clarion call?

@en

The siren song of bevacizumab: swan song or clarion call?

@nl

P1433

Q49818975-959D670F-FFE4-449D-B67E-7B6E9C41BBDA

P1476

Q49818975-4C6F8DB7-B964-4D78-B67C-E008E8BEEB0E

P2093

Q49818975-52628F38-CF17-48E6-B1BA-5901B8CCA996

Q49818975-FC92528D-2EAB-45A0-BC73-DCA94C9BFA35

P2860

Q49818975-22305005-EA39-424D-9D1E-396373591167

Q49818975-327C9E16-0F9B-449F-9DB8-598012D19B96

Q49818975-36839D99-F214-4417-923F-E934FCDBBDB6

Q49818975-3E755D39-A5F3-491E-97C3-B818DD583689

Q49818975-5ABCBA69-56FA-4F76-97DE-C610E813B426

Q49818975-6B61B94C-9B8A-422E-8393-0AD3623564A7

Q49818975-78E5017B-7F2F-47A7-9947-E2BFFAC8733A

Q49818975-8285E247-665B-4128-9F1F-40BA9126AB9B

Q49818975-90E70C21-86E4-4B52-8808-E58952039DDE

Q49818975-99ACF0D0-D2A7-4BA1-8CCE-FBF655534D5F

P304

Q49818975-125A3CA0-7B6F-458F-8748-E617F02E8385

P31

Q49818975-536E523D-58E5-4742-8070-7A3C331BE692

Q49818975-8daf8fd5-e39a-4ce0-afcf-555ce4c3aae3

P356

Q49818975-E432A1A2-9005-4CEA-9C28-6D71B378E9E4

P433

Q49818975-5F5DA02B-E3D5-47E6-B7D2-034512837D28

P478

Q49818975-71A8A22F-4F63-458A-9392-BC2C1F2DF37C

P577

Q49818975-729C2394-1577-4788-8A1F-63504AF90B15

P698

Q49818975-A84E3DBB-2447-4545-A21F-085F215FA723

P921

Q49818975-80BDCA01-7179-4CAA-9FB6-31FD38D5C54C

P932

Q49818975-1A677A96-8349-4716-AA06-8E665D2DE158

P356

P1433

P1476

The siren song of bevacizumab: swan song or clarion call?

@en

P2093

David Schiff

http://www.w3.org/2001/XMLSchema#string

Patrick Y Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study.

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.

Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials.

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial.

Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio.

P304

147-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOX244

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29365205

http://www.w3.org/2001/XMLSchema#string

P921

P932

5777485

http://www.w3.org/2001/XMLSchema#string